SCHEDULE 13G/A 0002068530 XXXXXXXX LIVE 1 Common stock, par value $0.0001 per share 09/10/2025 0001736730 Camp4 Therapeutics Corp 13463J101 ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR Cambridge MA 02139 Rule 13d-1(b) Rule 13d-1(c) Coastlands Capital LP b DE 0.00 4886722.00 0.00 4886722.00 4886722.00 N 9.99 IA PN Percentage calculated based on 20,161,073 shares of Common Stock outstanding on August 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025, plus 26,681,053 shares of Common Stock issued in a private placement transaction, which closed on September 11, 2025. The securities exclude shares of Common Stock issuable upon exercise of a pre-funded warrant in excess of the beneficial ownership limitation of 9.99%. This Amendment No. 1 to Schedule 13G is being filed solely to make a typographical rounding error correction in Item 11 of the cover sheet for each Reporting Person of the Schedule 13G filed on September 16, 2025 ("Schedule 13G"). With the exception of the typographical rounding correction in Item 11, all other information contained in the Schedule 13G remains unchanged. Coastlands Capital Partners LP b DE 0.00 4886722.00 0.00 4886722.00 4886722.00 N 9.99 PN Percentage calculated based on 20,161,073 shares of Common Stock outstanding on August 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025, plus 26,681,053 shares of Common Stock issued in a private placement transaction, which closed on September 11, 2025. The securities exclude shares of Common Stock issuable upon exercise of a pre-funded warrant in excess of the beneficial ownership limitation of 9.99%. Coastlands Capital GP LLC b DE 0.00 4886722.00 0.00 4886722.00 4886722.00 N 9.99 OO Percentage calculated based on 20,161,073 shares of Common Stock outstanding on August 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025, plus 26,681,053 shares of Common Stock issued in a private placement transaction, which closed on September 11, 2025. The securities exclude shares of Common Stock issuable upon exercise of a pre-funded warrant in excess of the beneficial ownership limitation of 9.99%. Coastlands Capital LLC b DE 0.00 4886722.00 0.00 4886722.00 4886722.00 N 9.99 HC OO Percentage calculated based on 20,161,073 shares of Common Stock outstanding on August 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025, plus 26,681,053 shares of Common Stock issued in a private placement transaction, which closed on September 11, 2025. The securities exclude shares of Common Stock issuable upon exercise of a pre-funded warrant in excess of the beneficial ownership limitation of 9.99%. Matthew D. Perry b X1 0.00 4886722.00 0.00 4886722.00 4886722.00 N 9.99 HC IN Percentage calculated based on 20,161,073 shares of Common Stock outstanding on August 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2025, plus 26,681,053 shares of Common Stock issued in a private placement transaction, which closed on September 11, 2025. The securities exclude shares of Common Stock issuable upon exercise of a pre-funded warrant in excess of the beneficial ownership limitation of 9.99%. Camp4 Therapeutics Corp ONE KENDALL SQUARE, BUILDING 1400 WEST, 3RD FLOOR, Cambridge, MA 02139. Coastlands Capital LP, a Delaware limited partnership ("Coastlands") Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership") Coastlands Capital GP LLC, a Delaware limited liability company (the "General Partner") Coastlands Capital LLC, a Delaware limited liability company ("Coastlands GP") Matthew D. Perry Coastlands and the General Partner are the investment adviser and general partner, respectively, of the Partnership. Coastlands GP is the general partner of Coastlands. Mr. Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Schedule 13G jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therin. In addition, the filing of this Schedule 13G on behalf of the Partnership should not be construed as an admission that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any Common Stock covered by this Schedule 13G. 601 California Street, Suite 1210, San Francisco, CA 94108 See Item 4 of the cover sheet for each reporting person. N IA HC Coastlands: 4,886,722 Partnership: 4,886,722 General Partner: 4,886,722 Coastlands GP: 4,886,722 Matthew D. Perry: 4,886,722 Coastlands: 9.99% Partnership: 9.99% General Partner: 9.99% Coastlands GP: 9.99% Matthew D. Perry: 9.99% % Coastlands: 0 Partnership: 0 General Partner: 0 Coastlands GP: 0 Matthew D. Perry: 0 Coastlands: 4,886,722 Partnership: 4,886,722 General Partner: 4,886,722 Coastlands GP: 4,886,722 Matthew D. Perry: 4,886,722 Coastlands: 0 Partnership: 0 General Partner: 0 Coastlands GP: 0 Matthew D. Perry: 0 Coastlands: 4,886,722 Partnership: 4,886,722 General Partner: 4,886,722 Coastlands GP: 4,886,722 Matthew D. Perry: 4,886,722 N The Partnership holds Common Stock, including shares of Common Stock issuable upon exercise of pre-funded warrants, for the benefit of its investors and has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, Common Stock, including shares of Common Stock issuable upon exercise of pre-funded warrants. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Coastlands Capital LP /s/ Mark Shamia 12/11/2025 Coastlands Capital Partners LP /s/ Mark Shamia 12/11/2025 Coastlands Capital GP LLC /s/ Mark Shamia 12/11/2025 Coastlands Capital LLC /s/ Mark Shamia 12/11/2025 Matthew D. Perry /s/ Matthew D. Perry 12/11/2025